hepatitis-b

Documents about hepatitis-b

• Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.#28420ClinicalTrials.gov
• Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI#905080ClinicalTrials.gov
• Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients#994374ClinicalTrials.gov
• Additional file 1 of Diagnostic capacity and utilization of Hepatitis B and C testing across multiple health care sectors in Vietnam#402224Figshare
• A Randomized Trial of Vaccine Adherence in Young Injection Drug Users#181591ClinicalTrials.gov
• Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B#843197ClinicalTrials.gov
• Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)#843697ClinicalTrials.gov
• The Role and Regulatory Mechanism of Germinal Center Immune Response in Hepatitis B Virus Infection#850160ClinicalTrials.gov
• Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule#855094ClinicalTrials.gov
• A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B#882144ClinicalTrials.gov
• The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students#882455ClinicalTrials.gov
• Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)#883504ClinicalTrials.gov
• A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.#883881ClinicalTrials.gov
• Non-Invasive Model for Fibrosis Regression in HBV Patients#918106ClinicalTrials.gov
• A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB#995356ClinicalTrials.gov
• The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection#905262ClinicalTrials.gov
• A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses#314403ClinicalTrials.gov
• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)#836986ClinicalTrials.gov
• A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV#837760ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)#912265ClinicalTrials.gov
• Risk Assessment of Long-Haul Truck Drivers#356556ClinicalTrials.gov
• REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection#877899ClinicalTrials.gov
• Terminator 2 Register#1032486ClinicalTrials.gov
• Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes#802178ClinicalTrials.gov
• ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis B#841371ClinicalTrials.gov
• Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy#890179ClinicalTrials.gov
• Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)#900422ClinicalTrials.gov
• Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF#901990ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients#982157ClinicalTrials.gov
• Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors#1010628ClinicalTrials.gov
• Nationwide seroprevalence study of hepatitis B and hepatitis C viruses among blood donors in Paraguay.#309124NCBI PubMed Central
• GUM Remote Testing v4.0#827879ClinicalTrials.gov
• Sonazoid Enhanced Liver Cancer Trial for Early Detection#993727ClinicalTrials.gov
• Serological and molecular detection of seropositive occult hepatitis B virus infection in hepatitis B surface antigen-negative sera at Hospital USM, Kelantan#190824USM Repository
• Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis#369890ClinicalTrials.gov
• The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B#886648ClinicalTrials.gov
• Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients#1033379ClinicalTrials.gov
• Prevalence of Hepatitis B Among Migrants Living in High-Income Countries With Low/Intermediate HBV Prevalence–A Systematic Review and Meta-Analysis#1040201Open Research
• A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™#195405ClinicalTrials.gov
• Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients#226314ClinicalTrials.gov
• Investigation of changes in irisin and nesfatin-1 levels in chronic viral hepatitis#446720Recep Tayyip Erdoğan University Institutional Repository
• TAF Real World Study for Universal Effectiveness#906181ClinicalTrials.gov
• Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients#838842ClinicalTrials.gov
• Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis B#910149ClinicalTrials.gov
• A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)#1032951ClinicalTrials.gov
• Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030: 2026 mid-term progress report#401516WHO IRIS
• Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive Individuals#848765ClinicalTrials.gov
• Patient-Centered Care and Asian Americans#994414ClinicalTrials.gov
• A cross-border seroprevalence study on HBV, HCV, HDV and HIV in remote Amazonian communities on the border between French Guiana and Suriname#219392PLOS
• Determinants of Hepatitis B vaccine uptake among health science students: A cross-sectional study in <i>Burao</i>, Somaliland#253532Europe PMC